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Introduction
Women with a family history of breast cancer are at increased 
risk of developing breast cancer themselves. Having one first-
degree relative （i.e., a parent, child, brother, or sister） who has 
experienced breast cancer increases the risk by 1.8 times relative 
to the risk with no first-degree relative; with two and three first-
degree relatives, the risk is increased by 2.9 and 3.9, respectively 
（Collaborative Group on Hormonal Factors in Breast Cancer, 
2001）.
Breast cancer is classified into three types according to 
heritability: hereditary breast cancer, caused by gene mutation 
in a reproductive cell; familial breast cancer, experienced by 
multiple blood relatives, regardless of heredity; and sporadic 
breast cancer, which is neither hereditary nor familial. Familial 
breast cancer accounts for 15%-20% of all breast cancers （Ochi 
& Yamauchi, 2017）. Of those with familial breast cancer, 26.7% 
test positive for the BRCA gene （a breast cancer susceptibility 
gene located at the 17th chromosome） and are diagnosed with 
hereditary breast cancer （Sugano et.al., 2008）. Approximately 
70% of BRCA1-positive breast cancers are triple-negative, 
in which the cancer cells test negative for estrogen and 
progesterone receptors and excessive human epidermal growth 
factor receptor type 2 （HER2） （Nakamura, 2012）. Triple-
negative breast cancer is highly malignant and difficult to treat 
because its growth is not supported by hormones, so hormone 
therapy is ineffective. Triple-negative breast cancer is, in general, 
highly malignant and difficult to treat because hormone therapy 
or HER2-targeting drugs are ineffective. Furthermore, this type 
of breast cancer is often found in women younger than 34 years 
old, whose prognosis is poorer compared to those older than 35 
years （Ohno, 2013）. Women with hereditary breast and ovarian 
cancer syndrome （HBOC）, a predisposition to a hereditary 
cancer caused by BRCA1/BRCA2 gene mutation, have 6 times 
the risk of developing breast cancer during their lifetime than 
women without the syndrome （Ochi & Yamauchi, 2017）. 
Thus, the characteristics of familial breast cancer include 
having multiple breast cancer patients among blood relatives, 
and those for hereditary breast cancer include development at 
a younger age and often high levels of pathological malignancy, 
such as with triple-negative breast cancer. An important issue 
with familial breast cancer is the need to support healthy female 
blood relatives of the patient because of their relatively high risk 
of developing the cancer. This is especially important for cancers 
that occur in young adults or have high malignancy. Early 
detection and treatment is important, because this makes the 
planning treatment strategy easier and reduces mortality, which 
is especially important for young women who may be about to 
experience life events such as marriage, pregnancy, and child-
rearing. When a patient is identified as having familial breast 
cancer, therefore, we should consider the whole family line that 
shares the patient’s genetic information.
When a second patient among blood relatives is diagnosed 
with breast cancer, familial breast cancer should be suspected. 
Familial breast cancer is defined either by three or more breast 
cancer patients among first-degree relatives or by two breast 
cancer patients among first-degree relatives of whom one is aged 
<40 years （early-onset）, exhibits bilateral breast cancer, or has 
metachronous multi-organ duplication cancer （Nomizu, 1996）. 
The diagnosis of a second breast cancer patient within blood 
relatives does not necessarily imply familial breast cancer, but 
the possibility of familiar breast cancer is increased, and support 
for the patient’s relatives should start on that basis so that the 
relatives receive the information and clarification they need as 
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soon as possible. The second, second patient within blood relatives 
were watched proband’s fighting life as her family, and she is 
cancer patients. When a patient understands that her cancer 
is not sporadic breast cancer, she can inform the appropriate 
information to relatives within her blood family line. Because the 
second patient to be diagnosed has a three-way standing position, 
as a member of the cancer-prone family, a cancer patient and an 
educator to persons who are yet to be diagnosed, she is key to the 
preventive approach for the family. We must therefore understand 
the experience of the second patient to be diagnosed and support 
her as a key person for protecting other family members.
There has been recent progress in genome medicine for 
hereditary breast cancer. The U.S. National Comprehensive 
Cancer Network （NCCN） guidelines recommend genetic 
counseling about the screening criteria, genetic testing, the 
surveillance of high-risk patients, preventive risk reduction 
surgery, and preventive drug administration （NCCN Clinical 
Practice Guidelines in Oncology, 2019）. In Japan, companion 
diagnostic tests （a type of genome testing） are being applied to 
investigate the effectiveness of poly （ADP-ribose） polymerase 
（PARP） inhibitors against the recurrence or metastasis of BRCA-
positive breast cancers.
Although researchers understand the effectiveness of genome 
medicine for hereditary breast cancer, for the present study we 
focused on familial breast cancer, which is broader than hereditary 
breast cancer to inform the patients’ relatives about their increased 
risk of familial breast cancer, and to provide them with support. 
There are three reasons for approach. First, addressing hereditary 
breast cancer patient requires genetic testing and a diagnosis of 
heritability, which can bring psychological difficulties. As of 2019 
in Japan, companion diagnostics for PARP inhibitors is covered 
by medical insurance （AstraZeneca., 2019）, whereas genetic 
testing for the patient and family is not. The genetic testing can 
therefore be an economic burden and can take time, but also until 
the results are obtained, this can present psychological difficulties 
for the family members. Because there is the possibility that 
the familial cancer is early onset and/or of high malignancy, 
the process of informing and supporting the relatives should be 
started as soon as possible. The second reason is that the NCCN’s 
screening criteria for genetic counseling includes ‘containing 
pancreatic cancer within blood relatives’; this is based on medical 
and professional evidence, but it may be difficult to understand 
for a patient without professional knowledge, especially if she 
is the first to be diagnosed and may be unsure why her family 
members are suspected of being at risk of heritability. Conversely, 
the heritability risk is easier to understand when a second family 
member receives a diagnosis of breast cancer, even for patients 
with little medical knowledge, and family members are generally 
more ready to receive information. The third reason is that, 
although there have been rapid advances in genome medicine, all 
genes related to breast cancer may not yet have been discovered. 
Thus, it may be important to immediately support the second 
patient who bears a higher risk for familial breast cancer in 
order to reduce missing patients potentially at risk from these 
undiscovered mutations.
The final goal of our project is to establish support for family 
members at risk of familial breast cancer. It is important for 
family members to develop coping strategies to enhance their 
adaptability so that the family line including healthy members can 
overcome demerits by taking over the gene and can continue. For 
this purpose, it is necessary to investigate nursing strategies based 
on the experience of the second family members to be diagnosed 
who have a three-way standing position. However, there have 
been few previous studies about such experience in familial 
and hereditary breast cancer, including the studies on a young 
daughter （Johnson & Pascal, 2016）, sisters （Metcalfe et al., 2013; 
Phillips & Cohen, 2011）, and female family members （Hartman 
et al., 2015; Lancaster, 2005; Chalmers et al., 2003; Martin & 
Degner, 2006; Neise et al., 2001）. In addition, there have been 
reports of the experience of suffering among blood relatives 
（Metcalfe et al., 2013）, the meaning of heritability （Maheu, 
2009）, and the relationship between risk, preventive behavior, and 
coping （Lancaster, 2005; Martin & Degner, 2006; Neise et al., 
2001; Hartman et al., 2015; Cabrera et al., 2009）. However, there 
have been no previous studies about the experiences of the second 
patient who has a three-way standing position; therefore, this new 
study was designed to evaluate the experiences of such family 
members.
Purpose of the study
The purpose of the study is to clarify the coping process 
against familial breast cancer by the second patient within blood 
relatives to be diagnosed with breast cancer, and to discuss nursing 
strategies to enhance adaptation in a consanguineous family 
through support of the second patient.
Methods
Ⅰ．Definition of terms
1. Second patient in a consanguineous family: The second patient 
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among first-degree relatives to be diagnosed with breast cancer 
and with no evidence of a third patient.
2. Familial breast cancer: Familial breast cancer was used to 
include the suspected cases of it.
3. Proband: The first person to be diagnosed with breast cancer in 
our participants’ consanguineous family.
4. Non-patient relatives: Healthy females in a participants’ family 
with possible familial breast cancer.
5. Coping process: According to the Cambridge dictionary （2019）, 
“attitude” is defined as how you think or feel about something, 
and “coping” is defined as doing something well in a difficult 
situation. The term “coping process” thus refers to how one 
should think or feel in a certain situation （attitude）, how one 
should eventually do something well in a difficult situation 
（coping）, and how these change over time. Thus, in this study, 
the coping process is presented as a sequence of attitude and 
coping categories with proband’s and own cancer.
Ⅱ．Participants
Patients were selected based on the following four criteria.
1. The second breast cancer patient among first-degree relatives.
2. Survivors entering the plateau phase without recurrence or 
metastasis. Survivors in plateau are defined as those that have 
completed initial treatment and follow-up, or if hormone 
receptor-positive, patients on continued endocrine therapy. 
Recurrent and metastatic patients were excluded because 
we wanted to focus on attitude and coping with familial 
breast cancer rather than thoughts of death and experiences 
associated with declining physical condition.
3. Patients with the cognitive capacity to describe/discuss their 
own experiences.
4. They were Japanese. Because this was a qualitative study, it was 
important for the participants to be able to understand the 
language, context, medical system, and cultural background. 
The Japanese researcher interviewed all the participants in 
Japanese.
5. Agreeing to participate in the study and providing written 
consent.
Ⅲ．Data collection
１．Participant enrollment
The doctor in charge at the research cooperation facility 
introduced the researchers to candidates for this study. The 
researcher confirmed with the doctor that there had been no 
significant change in the patient’s pathological conditions, 
and then explained to the candidate about the purpose and 
methods of the study, and ethical consideration. In addition, we 
explained to the candidate that if she wished not to participate 
or subsequently to withdraw from the study, but she felt unable 
to say this to the researcher, there were other people she could 
inform about this. We guaranteed she would not be under any 
disadvantage if she did not participate or withdrew.
２．Method of data collection
Data was corrected via semi-structured interview by researcher’s 
native language. We listened with empathy using an interview 
guide to promote openness and truthfulness of the participants. 
We added open-ended questions to allow elaboration by the 
speaker beyond direct answers. We made word-for-word 
recording with participants’ permission. Interviews were carried 
out from August 2016 to December 2017.
３．The interview guide questions
1） Before breast cancer diagnosis, what were your attitudes 
toward breast cancer, and how did you cope？ Why did you do 
so？
2） What were your attitudes toward the proband’s breast cancer, 
and how did you cope？ Why did you do so？
3） What were your attitudes toward your own breast cancer, and 
how do you cope？ Why do you do so？
4） What were your attitudes toward becoming multiple breast 
cancer patients in your family, and how do you cope？ Why do 
you do so？
Ⅳ．Analysis
Qualitative and inductive analysis methods were applied. We 
read the word-for-word records thoroughly and conducted a 
three-step analysis by researcher’s native language: 1） analysis 
of attitude, 2） analysis of coping, and 3） combining the attitude 
and coping categories of the second patients and outlining the 
second patient’s coping process. Finally, we performed a back 
translation to check the context was correctly understood and 
that the categories had been translated accurately from Japanese 
to English.
１．Analysis of attitude for multiple patients with breast 
cancer within blood relatives
1） Point-of-view about attitude analysis and answering the 
question, “How does the second patient think or feel about her 
own cancer, the proband’s cancer, and about multiple people 
within blood relatives being diagnosed with breast cancer？”
 After careful reading, we extracted statements regarding the 
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point-of-view of analysis from all participants’ word-for-word 
records.
2） We gathered sentences with similar meanings and made sub-
categories.
3） We then gathered sub-categories with the same meanings 
and made categories. In this document, categories of attitude 
are shown as ［1.＊＊＊］［2.＊＊＊］.
２．Analysis of coping for multiple patients with breast 
cancer within blood relatives
1） Point-of-view about coping analysis is to answer the question, 
“How does the second patient cope with her own cancer, 
with the proband’s cancer, and with the fact that multiple 
people within blood relatives might be diagnosed with breast 
cancer？” 
2） After careful reading, we extracted statements regarding the 
point-of-view of analysis from all participants, and made sub-
categories and categories. Procedure of analysis of coping 
was same as that for analysis of attitude. In this document, 
categories of coping are shown as 〈A.＊＊＊〉〈B.＊＊＊〉.
３．Synthesizing the attitude and coping categories and 
outlining the second patient’s coping process
1） After careful categorization of the attitude and coping 
categories separately, we associated ［category of attitude］ 
and 〈category of coping〉 to explain the point-of- view and 
illustrated the relevance in diagrams. Point-of-view about 
process analysis is to answer the question “How does the 
second patient think/feel and cope with multiple people being 
diagnosed with breast cancer in her consanguineous family？ 
How can we change the second patient’s thinking/feeling and 
coping in time axis？”
2） We identified some relevance of categories in diagrams, which 
had larger meanings and explained certain process. We extracted 
and named the meanings as core categories. Core categories are 
shown in italics and underlined, for example,  Ⅰ.＊＊＊＊,  Ⅱ.＊＊＊＊.
3） We then constructed story lines by expressing core categories 
and diagrams, using ［category of attitude］ and 〈category of 
coping〉.
4） We then reassessed the word-for-word records to check 
whether all participants’ experiences can be explained by core 
categories and the diagram. If we could not, we discarded 
the diagram and repeated steps （1） to （3） until a completed 
diagram was obtained.
４．Back translation from Japanese categories to 
English categories
The data gathering and analysis for this study were conducted 
in Japanese, the researchers’ mother tongue, to ensure the 
meanings and essence of the participants’ responses were 
properly understood. However, the results will be published 
in English so they can be shared internationally. We therefore 
performed a back translation following the steps listed below 
to ensure the categories were accurately expressed in English. 
The back translation was applied to the categories and core 
categories. In addition, back translation was applied to the 
discussion of the characteristics of the coping processes of the 
second patients among blood relatives in the Discussion section. 
The back translation was performed by the academic translation 
company Ulatus Worldwide （Crimson Interactive Pvt. Ltd）. 
The back translation process used the following steps:
1） The researchers translated the core categories, categories of 
attitude, and categories of coping from Japanese into English, 
and these were checked by native English speakers. 
2） A professional translator then translated them from English 
into Japanese.
3） A different professional translator compared the original 
Japanese categories and the back-translated Japanese categories, 
and corrected the English categories accordingly.
4） The researchers calculated the concordance rate between the 
original Japanese categories and the back-translated Japanese 
categories.
Ⅴ．Validation of analysis
An expert on qualitative and inductive research supervised the 
entire process.
Ⅵ．Ethical considerations
This study was performed in accordance with The Declaration 
of Helsinki.
We explained the study goals and obtained written and oral 
consent from all participants. After explaining the purpose and 
methods of the study, we informed participants that they were 
free to join or not and that refusal conferred no disadvantage. 
Also, we stressed that participants were not compelled to discuss 
anything they were not comfortable revealing. We assessed 
participants’ physical and psychological conditions between and 
after interviews and stopped interviews for nursing care if patients 
appeared stressed or requested a rest. The study proposal was 
approved by the Ethics Committee of the Department of Nursing, 
Graduate School of Health Sciences, Okayama University （No. 
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2016 March 23, D15-05）, and Yodogawa Christian Hospital （2016 
August 30, no individual approval number）.
Results
Ⅰ．Overview of participants
Sixteen breast cancer patients at two hospitals in Japan 
participated in this study （average age 55.2 ± 10.8 years）, one 
of which had cancer in both breasts. Eleven had received total 
mastectomy and five partial mastectomy. Three patients were 
in Stage 0, five in Stage Ⅰ, seven in stage Ⅱ, and two in stage Ⅲ
（including the one bilateral patient）.
The proband is the second patient’s mother in eight cases, the 
second patient’s older sister in five cases, and the second patient’s 
younger sister. The proband is alive in 10 cases and is dead in six 
cases. （Table 1）.
The hospitals were breast cancer specialty hospitals located in 
a large city in west Japan; one was a general hospital, the other 
a clinic. They have no genetic counseling, and the patients who 
wanted to receive genetic testing were referred to other medical 
facilities. At the general hospital, three certified oncology nurse 
specialists and one certified nurse for breast cancer provides 
specialist care. At the clinic, one highly specialized nurses 
with more than 10 years of experience of breast cancer nursing 
provides specialist care.
Table 1　Overview of participants
Case age operative method
endocrine 
therapy
simultaneity/
metachronous 
breast cancer
Stage
proband
alive persons into first-degree 
affinity personrelationship alive/dead
period from 
proband’s 
diagnosis to 
now （year）
Ａ Early  
60s
left:
  Bt＋AX
right: 
  Bt＋SLNB
〇 simultaneity 
and both sides 
breast cancer
left: Ⅱ 
right: 0
mother alive 20 mother, small sister, first 
daughter
Ｂ Late 
40s
Bp＋SLNB 〇 none Ⅰ mother alive 15 father, mother, old sister
Ｃ Early 
60
Bt＋SLNB 〇 none Ⅰ old sister dead   7 mother, small brother, first 
daughter, second daughter, 
first son
Ｄ Late 
40s
Bp＋SLNB none 0 old sister alive 10 old sister, four people of old 
brother, first daughter
Ｅ Late 
60s
Bt＋AX none Ⅲ old sister dead   7 first daughter, second 
daughter
Ｆ Early 
40s
Bp＋SLNB 〇 none Ⅱ mother dead   7 father, small sister
Ｇ Early 
40s
Bp＋AX 〇 none Ⅱ mother alive   4 father, mother, old brother, 
first son
Ｈ Early 
50s
Bt＋SLNB 〇 none Ⅱ mother alive   8 mother, small sister
Ｉ Late 
60s
Bt＋SLNB 〇 none Ⅱ mother dead 45 old sister, first son
Ｊ Late 
60s
Bt＋AX none Ⅲ old sister alive   5 2 people of old sister, old 
brother
Ｋ Early 
50s
Bt＋SLNB 〇 none I small sister alive   4 father, mother, small sister, 
first son
Ｌ Early 
50s
Bt＋SLNB 〇 none Ⅱ mother dead   7 first daughter, second 
daughter
Ｍ Early 
70s
Bp＋SLNB none I small sister alive   1 small sister, first son, first 
daughter
Ｎ Early 
40s
Bt＋SLNB 〇 none I small sister alive   5 father, mother, small sister
Ｏ Late 
60s
Bt＋SLNB none 0 old sister alive   2 2 persons of old sister, 2 
persons of old brother
Ｐ Late 
40s
Bt＋AX none Ⅱ mother dead   9 father, small sister, small 
brother
note: Bt; whole breast, Bp; part of breast, Ax; axillary lymph nodes, SLNB; Sentinel lymph node biopsy 
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Ⅱ．Overview of analysis
Based on the narratives of sixteen participants, nine categories 
of second patients’ attitude for people within blood relatives 
who were diagnosed with breast cancer as well as 12 categories 
of their coping were extracted. Then, when these attitude and 
coping categories were integrated, five core categories indicating 
the second patients’ coping process against familial breast cancer 
were obtained.
By back translation, the concordance rate between the original 
and back-translated Japanese categories was 78% for the nine 
attitude categories; of these, four showed complete concordance, 
two showed concordance but needed modification for more 
sophisticated expression, and three needed modification because 
of a partial mismatch. Similarly, the concordance rate for the 
12 coping categories was 83%; of these, four showed complete 
concordance, six showed concordance but needed modification 
for more sophisticated expression, and two required modification 
because of partial mismatch. The concordance rate for the five 
core categories was 60%; three showed complete concordance, 
none needed modification for more sophisticated expression, and 
two required modification because of partial mismatch.
Ⅲ．Categories of second patients’ attitude for multiple 
people within blood relatives being diagnosed with 
breast cancer
Attitude of breast cancer by the second patient was 
summarized into nine categories and 22 sub-categories （Table 
2）.  The nine categories are described below.
1. ［1. Encountering proband’s breast cancer and warning about 
own breast cancer risk］
In many cases, second patients reported touching the lump 
and seeing the surgical wound after the proband’s mastectomy. 
The second patient reported thinking that they may also soon 
develop breast cancer and regarded the proband’s cancer as a 
warning.
2. ［2. Assume no relationship between proband’s breast cancer 
and personal risk］
In some cases, the second patient thought that the 
proband’s cancer was unrelated to her risk and that she would 
not develop breast cancer.
3. ［3. Proband’s breast cancer enters own subconscious and raises 
instinctive suspicion over small breast abnormalities］
Some second patients forgot about the proband’s caution 
and did not regularly think about breast cancer in daily 
life prior to diagnosis. However, noticing any small breast 
abnormality brought back memories of touching or seeing the 
proband’s breast cancer, and made these women realize that 
they may also develop breast cancer.
4. ［4. Realizes that heredity influences breast cancer onset］
When some second patients were diagnosed with breast 
cancer, they believed that heredity influenced their breast 
cancer development because they and their proband share the 
same DNA.
5. ［5. Prognosis prediction and comparison of breast cancer 
based on the proband’s illness］
Many second patients believe that they will have the same 
experience as the proband due to shared susceptibility. If the 
proband died, the second patient fears her own death, or if 
proband is alive, she believes she will survive.
6. ［6. Proband rescued me and she is irreplaceable］
Many second patients appreciate the proband because they 
were encouraged to seek breast cancer treatment early by the 
proband. Thus, the proband’s advice is supportive and effective.
7. ［7. Worries about relatives who are at high risk of breast 
cancer］
The second patient now knows that breast cancer risk is 
enhanced in close relatives （daughters, sisters, and nieces）, 
and worries that they will also develop breast cancer.
8. ［8. Deny uniqueness of the family with two members who are 
breast cancer patients］
Although the second patient knows her own family may 
have familial breast cancer, she still thinks her family tree is 
not abnormal as there are a lot of patients in the world.
9. ［9. Provide enlightenment about breast cancer beyond own 
family］
Many second patients seek to enlighten not only close 
relatives but also acquaintances about breast cancer.
Ⅳ．Categories of second patients’ coping with multiple 
people within blood relatives being diagnosed with 
breast cancer
Second patient’s strategies for coping with breast cancer was 
gathered into 12 categories and 19 sub-categories （Table 3）. 
1. 〈A. Memory of proband’s breast cancer as a shock〉
Second patients often coped by remembering the proband’s 
illness, which became a cautionary story.
2. 〈B. Expect to develop breast cancer because of proband〉
Second patients expected to develop breast cancer based on 
the proband’s breast cancer.
3. 〈C. Effort for early detection of breast cancer〉
Many second patients coped by employing preventive 
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behaviors. By expecting own breast cancer, the second patient 
acted to prevent its occurrence.
4. 〈D. I worry about onset of breast cancer, but I do not take any 
action〉
Some second patients coped by not behaving （i.e., accepting 
it as inevitable）. The second patient expects to develop breast 
cancer, and so does not act to prevent it.
5. 〈E. Disconnect from breast cancer〉
Other second patients coped by disconnection. Although the 
second patient expects to develop breast cancer, she does not have 
the will to confront it, so she detaches herself from breast cancer, 
even though she knows there is breast cancer into her family.
6. 〈F. Small abnormalities cause suspicion of breast cancer onset〉
Some second patients cope by utilizing caution. Based on the 
proband’s caution, when the second patient notices even small 
abnormalities, she believes these are signs of breast cancer.
7. 〈G. Accept breast cancer by heredity as destiny〉
Other second patients cope by acceptance. The second 
patient accepts that breast cancer is her destiny by belonging 
to this family as it is hereditary. However, her understanding of 
heredity as being transmitted to the next generation is different 
from the precise medical definition of “heredity.”
Table 2　Second patients’ attitudes of breast cancer
［Category］
Sub-category case
［1. Encountering proband’s breast cancer serves and warning about own breast cancer risk］
1 I cannot forget the feeling of the proband’s breast cancer lump when I touched it at the first time. C, J
2 I was shocked when I saw the proband’s surgical wound and chest without mammary tissue. D
3 Because breast cancer might be genetic and I have proband in my family, I am determined that I will now 
have breast cancer. 
G, K, O
［2. Assume no relationship between proband’s breast cancer and personal risk］
4 Although I understand there is proband in my family, I believe I will not have breast cancer because my  
family does not have hereditary cancer.  
A, E, J
5 There is no relationship between me and breast cancer even if my relative has breast cancer. A, N
［3. Proband’s breast cancer enters own subconscious and raises instinctive suspicion over small breast abnormalities］
6 I realized I had breast cancer intuitively, when I noticed small abnormal changes in my breast. A, C, N, P
［4. Realizes that heredity influences breast cancer onset］
7 Proband thinks that I inherited breast cancer from her and feels guilty for me. D, F, G
8 The reason for my breast cancer is heredity. B, I
9 There are two types: heredity test is beneficial for coping against breast cancer; heredity test is not beneficial 
and brings fear.
A, N
［5. Prognosis prediction and comparison of breast cancer based on the proband’s illness］
10 I am fearful that my destiny will be same as the proband’s and my illness process will be like the proband’s 
illness process.
E, I, L, P
11 I think that mine and the proband’s disease process are the same because I and the proband share the same 
gene. But this thought is biased; our processes are different. Therefore, I must correct the bias.
A, N
［6. Proband rescued me, and she is irreplaceable］
12 I am lucky that I detected breast cancer early due to proband’s breast cancer. D, F, G, O
13 I and proband share bonds because we experience sufferings of breast cancer together. F, K, M, N, P
14 I have seen how proband faced breast cancer. Therefore, I am not too fearful of  breast cancer. B, C, D, G
15 I understand proband’s suffering of breast cancer only after experiencing it myself. I, N, P
［7. Worries about relatives who are at high risk of breast cancer］
16 A healthy woman in my family has more serious anxiety than me because she has two patients （proband and 
me）  in family although I have only proband.
E, F, H, P
17 I hope healthy women with hereditary risk in my family will practice preventive behavior. B, C, D, E, F, G, O, P
18 It is difficult to know how to advise healthy women in my family. A, B, C, D, H, J, 
19 I was helped and I thank the non-relatives’s solicitude and kindness. B, L, P
［8. Deny uniqueness of the family with two members who are breast cancer patients］
20 There are numerous breast cancer patients in the world. Two patients in my family tree is not a unique thing. G, I, K, M, P
［9. Provide enlightenment about breast cancer beyond own family］
21 Reports by mass media are significant for enlightenment on breast cancer and promote other person’s 
empathy against patients.
A, B, D, I, M, N, O, P
22 I hope to enlighten not only my family but also the society because I am the second patient in my family. G, I, M, N, O, P
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8. 〈H. Superimpose own and proband’s experience〉
Second patients also coped by comparing themselves to the 
proband. Second patients know about the proband’s illness 
and expect their illness to resemble that of the proband.
9. 〈I. Appreciation for the proband and empathizing with the 
proband〉
Some second patients coped by appreciating, empathizing, 
and sharing. Second patients appreciated the proband as she 
facilitated early detection of breast cancer. The second patient 
and proband share suffering and empathize with each other. If 
the proband had died already, the message left tightened the 
bond.
10. 〈J. Encouraging prevention according to each healthy 
relative’s condition〉
Many second patients coped by protecting blood relatives. 
　There is no uniform method for prevention of breast 
cancer, so the second patient uses a trial and error approach 
depending on each blood relatives’ personality.
11. 〈K. Hesitate and choose to receive genetic testing〉
Some second patients coped by decision-making. Second 
Table 3　Second patient's coping strategies
〈Category〉
Sub-category Case
 〈A. Memory of proband’s breast cancer as a shock〉
a. I remember proband’s breast cancer with high shock. A, C, D
 〈B. Expect to develop breast cancer because of proband〉
b. Breast cancer is familial because of the example set by the proband, and I expect I will develop breast cancer. H, I, K, O
〈C. Effort for early detection of breast cancer〉
c. I practice self-exams and receive medical exams because of my relative’s breast cancer. D, K, L
〈D.  I worry about onset of breast cancer, but I do not take any action〉
d. I know breast cancer is hereditary, but a medical exam has been delayed because of my busy daily life. H, I, K
〈E. Disconnect from breast cancer〉
e. I have a relative with breast cancer, but I believe I will not develop breast cancer, so I forget about it in daily 
life.
A, E, F, N
〈F. Small abnormalities cause suspicion of breast cancer onset〉
f. From memory of the proband’s breast cancer, when I notice a small breast abnormality, I undoubtedly 
believe that it is breast cancer.
A, C, D, G, K, P
〈G. Accept breast cancer  by heredity as destiny〉
g. I realize that my breast cancer is hereditary, so I will inherit the disease. B, I
〈H. Superimpose own and proband’s experience〉
h. Because of the same blood line, I superimpose my illness process and proband’s illness process. E, P
〈I. Appreciation for the proband and empathizing with them〉
i. I appreciate proband’s comfortable attitude and share experiences of breast cancer with her. M, N, O
j. Due to warnings from the proband, they found breast cancer early and started treatment early. D, F, G, O, P
k. I regret not to have noticed proband’s suffering. I, P
〈J. Encouraging prevention according to each healthy relative’s condition〉
l. I gave advice to a young close relative against breast cancer.  The reason is that my family tree has a risk of 
heredity because there are 2 breast cancer patients in my family.
C, D, F, M, O
m. Because I hope my close young relatives have knowledge of and prevent breast cancer, I showed my surgical 
wound to them.
E, D, P
n. I explained my illness to close relatives. But after that, I checked that they do not fear breast cancer and 
watch over their lives.
A, C, H, D
o. I approach close relatives to promote the prevention of breast  cancer, and I think about how to approach 
according to each relative’s characteristics; for example, their personality and age.
A, B
p. I help close relatives cope with breast cancer and to find it early for oneself because we have two patients in 
the family.
E, F, H, P
〈K. Hesitate and choose to receive genetic testing〉
q. I was influenced by the report of an actress with heredity cancer and decided to undergo heredity testing to 
cope with heredity breast cancer.
N
r. I did not undergo heredity testing because I feared knowing the result of high risk. A, H
〈L. My persuasive enlightenment as a second patient in my family 〉
s. My advice is persuasiveness because I am the second patient in my family. C, F, G, M, N
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patients recognize that female relatives are also at risk and 
weigh the merits and demerits of clarifying whether the 
family harbors a breast cancer risk gene. The second patient 
often worries and hesitates before deciding.
12. 〈L. My persuasive enlightenment as a second patient in my 
family〉
Second patients also coped by enlightenment. The second 
patient spreads her concern from her own family to other 
people. As the second patient has unique experience, she can 
be persuasive.
Ⅴ．Synthesis of attitude and coping categories, and 
outlining the second patients’ coping process against 
familial breast cancer
9 of ［category of attitude］ and 12 of 〈category of coping〉 
were associated according to the point-of-view about process 
analysis, the second patients’ coping process was illustrated 
by the diagram （See Fig.1）. This analysis yielded five core 
Fig.1　Synthesis of attitude and coping categories, and outlining second patients’ coping process against familial breast cancer
［1. Encountering proband’s breast cancer and warning about own breast cancer risk］
〈A. Memory of proband’s breast cancer as a shock〉 → ［2. Assume no relationship between proband’s breast cancer 
and personal risk］
↓
〈E. Disconnect from breast cancer〉
〈B. Expect to develop breast cancer because of proband〉
〈C. Eort for early detection of breast cancer〉
〈D. I worry about onset of breast cancer, but I do not take any action〉
［3. Proband’s breast cancer enters own subconscious and raises instinctive suspicion over small breast abnormalities］ 
〈F. Small abnormalities cause suspicion of breast cancer onset〉
Ⅰ. Caution without enforcing
Ⅱ. Intuition with high sensitivity
Before onset
Breast cancer signs
［4. Realize that heredity inuences breast cancer onset］ 
〈G. Accept breast cancer by heredity as destiny〉 
［5. Prognosis prediction and comparison of breast cancer based on the proband’s illness］  
↓
〈H. Superimpose own and proband’s experience〉 
↓
［6. Proband rescued me and she is irreplaceable］ 
↓
〈I. Appreciation for the probandand empathizing with the proband〉
［7. Worries about relatives who are at high risk of breast cancer］ 
↓
〈J. Encouraging prevention according to each healthy relative’s condition〉
After onset
〈K. Hesitate and choose to receive genetic testing〉 
［8. Deny uniqueness of the family with two members who are breast cancer patients］  
↓
〈L. My Persuasive enlightenment as a second patient in my family〉  
↓
［9. Provide enlightenment about breast cancer beyond own family］
Ⅴ. Advocating beyond the family without obsessing with heredity
Ⅳ. Advocating for blood relatives 
Ⅲ. Proband as a good bellwether
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categories; Ⅰ. Caution without enforcing,  Ⅱ. Intuition with high 
sensitivity, Ⅲ. Proband as a good bellwether, Ⅳ. Advocating for 
blood relatives, and Ⅴ. Advocating beyond the family without 
obsessing with heredity. We show the story lines below.
１．Before onset: Ⅰ. Caution without enforcing
The second patient stating ［1. Encountering proband’s breast 
cancer and warning about own breast cancer risk］ has 〈A. 
Memorized the proband’s breast cancer as a shock〉.
Second patients who have 〈A. Memorized proband’s breast 
cancer as a shock〉, may also ［2. Assume no relationship between 
proband’s breast cancer and my risk］ and 〈E. Disconnect from 
breast cancer〉 in daily life.
On the other hand, second patients who 〈B. Expect to 
develop breast cancer because of proband 〉 were divided into 
two patterns: 〈C. Effort for early detection of breast cancer〉 and 
〈D. I worry about onset of breast cancer, but I do not take any 
action〉.
２．Appearing at first signs of breast cancer: Ⅱ. Intuition 
with high sensitivity
When the second patient notices signs, ［3. Proband’s breast 
cancer enters own subconscious and raises instinctive suspicion 
over small breast abnormalities］, and she 〈F. Small abnormalities 
cause suspicion of breast cancer onset〉.
３．After onset （1）: Ⅲ. Proband as a good bellwether
After developing breast cancer, the second patient ［4. Realizes 
that heredity influences breast cancer onset］ and 〈G. Accepts 
breast cancer by heredity as destiny〉. She also thinks that ［5. 
Prognosis prediction and comparison of breast cancer based 
on the proband’s illness］, and 〈H. Superimposes own and 
proband’s experience〉, so she expects and copes with difficulties 
of treatment and symptoms. As the proband provided useful 
information and understanding, and facilitated early detection, 
the second patient thinks that the ［6. Proband has rescued me, 
and she is irreplaceable］ and she has an 〈I. Appreciation for the 
proband and empathizes with the proband〉.
４．After onset （2）: Ⅳ. Advocating for blood relatives
The second patient, who ［4. Realizes that heredity influences 
breast cancer onset］ and 〈G. accepts breast cancer by heredity as 
destiny〉, then ［7. Worries about relatives who are at high risk of 
breast cancer］ because risk is heightened by the appearance of 
two patients in one family. She thus tries to prevent breast cancer 
in her blood relatives by 〈J. Encouraging prevention according to 
each healthy relative’s condition〉.
５．After onset （3）: Ⅴ. Advocating beyond the family 
without obsessing with heredity
Second patients who ［4. Realize that heredity influences 
breast cancer onset］ waver over whether to have genetic testing 
〈K. Hesitate and choose to receive genetic testing〉, because 
she worries that knowing will negatively impact younger blood 
relatives. Although she ［4. Realizes that heredity influences 
breast cancer onset］, she ［8. Deny uniqueness of the family with 
two members who are breast cancer patients］ and disregards or 
ignores whether or not her family has hereditary breast cancer.
On the other hand, she continues 〈L. My Persuasive 
enlightenment as a second patient in my family〉, and her actions 
are spread ［9. Provide enlightenment about breast cancer beyond 
own family］, and she becomes an advocate to all women.
Discussion
Coping process against familial breast cancer by a second 
patient within blood relatives is explained by five core categories: 
Ⅰ. Caution without enforcing, Ⅱ. Intuition with high sensitivity, Ⅲ. 
Proband as a good bellwether, Ⅳ. Advocating for blood relatives, and 
Ⅴ. Advocating beyond the family without obsessing with heredity. 
In this section, we discuss 1） characteristic experiences of the 
second patient （See Fig.2）, 2） nursing strategies to enhance the 
coping ability in the consanguineous family through the second 
patient’s support, and 3） limitations of the study. 
Ⅰ．Characteristic experiences of the second patients
１．Forgetting breast cancer in health, working intuition 
for coping at contingency
The core category before onset was Ⅰ. Caution without 
enforcing. In other words, although the second patient accepted 
the proband’s breast cancer with impact and recognized this 
event as an indication for “caution,” only some actively coped 
through behavior promoting early detection, while others 
denied the relation between the proband cancer and their risk, 
or regarded cancer/health as inevitable regardless of actions. On 
the other hand, when the second patient saw potential signs of 
breast cancer, it retrieved memories of touching or seeing the 
proband’s cancer. The second patient thus understands having 
cancer by intuition, and seeks diagnosis as soon as possible （Ⅱ. 
Intuition with high sensitivity）.
Why do some second patients not make the connection 
between caution and preventive action？ Japan has been 
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experiencing several megathrust earthquakes since ancient times. 
Although citizens understand that mega-earthquake will occur, 
we do not think about them in daily life. But if one does occur, 
we are able to cope as individuals and institutions （local and 
central governments）.
Non-patients in families with at least two breast cancer 
patients also understand that they are at high risk, and can 
cope with a personal diagnosis. However, continuing to practice 
preventive behavior forces the second patient to confront the 
reality that they are in a high-risk family as well as the other 
negative aspects of cancer. This situation may cause suffering in 
non-patients because like an earthquake, breast cancer may or 
may not occur, and if it occurs, it may be next year or 30 years in 
the future. In addition, non-patients have expectations or plans 
such as falling in love, marriage, and having children. Despite 
the real possibility of breast cancer, making future decisions on 
the assumption of developing breast cancer will interfere with 
having a fulfilling life.
Neise et al., （2001） found that increased risk perception had 
negative effects on participation in recommended breast cancer 
screening, and our study provides a plausible explanation. Thus, 
appropriate care for non-patients should not stress excessive 
caution and stoke anxiety, but rather should increase sensitivity 
to enhance natural suspicion and the ability to cope with breast 
cancer as soon as abnormalities are noticed.
２．Proband becomes a partner for fighting the illness 
together
After disease onset, two of three core categories are Ⅲ. 
Proband as a good bellwether and Ⅳ. Advocating for blood relatives. 
Based on the example of the proband, the second patient may 
achieve early detection and receive useful information from the 
proband. Further, the second patient and proband may provide 
mutual support to each other and may together try to protect the 
other healthy females within blood relatives from breast cancer. 
Therefore, the proband is a pioneer and bellwether for the 
Fig.2　Characteristics of Second Patients’ coping process against familial breast cancer
Before onset:
Breast cancer signs:
After onset:
Realize that heredity inuences breast cancer  
Ⅲ. Proband as a good bellwether 
Ⅳ. Advocating for blood 
relatives 
Accept breast cancer by heredity as destiny 
Ⅱ. Intuition with high sensitivity 
Ⅰ. Caution without enforcing 
Ⅴ. Not obsessing with heredity 
↓ 
advocating beyond the family  
Forgetting breast 
cancer in a good health condition, 
as well as working intuition for   
coping at contingency 
 Proband becomes
a partner for ghting the
illness together 
Protecting non-patient relatives 
by becoming  
two types advocators 
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second patient.
A diagnosis of idiopathic breast cancer has a strong impact, as 
the patient will experience anxiety and uncertainly compounded 
by lack of knowledge about breast cancer （“the previously 
invisible”） （Mehrabi et al., 2016）. Indeed, the idiopathic breast 
cancer patient is usually the first patient in her family, and she 
does not have a role model. Therefore, she feels fearful and 
helpless stepping into an unknown world. On the other hand, the 
second patient has such a role model in the proband. The proband 
provides an example of the disease process and the associated 
suffering and worry that must be overcome. If the proband 
survives without recurrence, the second patient will tend to think 
positively regarding their own chances of survival. By adopting 
the proband as bellwether, the second patient is receiving 
guidance and direction.
Second, our data showed that the second patient superimposes 
their own illness on that of the proband’s. The proband’s 
illness influences attitude by the second patient. Familial and 
hereditary breast cancer are characterized by earlier onset and 
high aggression, so the second patient sees the suffering and 
possible death of the proband, which may be an additional source 
of trauma. Research on healthy women with a family history 
of breast cancer or having high risk of heredity has revealed 
maternal absence distress （Johnson & Pascal, 2016） and grief over 
actual and potential familial loss （Underhill el al., 2012） as major 
traumas.
On the contrary, our results did not show suffering and trauma 
from proband’s dying and death in spite of 6 of 16 participants 
experiencing the proband’s death and some of these participants 
reporting that “maybe I will die.” The reasons provided by our 
participants were “proband was too late, but I can find it early,” 
“when （the proband） died, she did not show her suffering 
to the second patient intentionally,” or “I do not remember 
proband’s death, because my concern was low before my breast 
cancer.” In other words, some of our participants were not aware 
of the proband’s true suffering. Therefore, although second 
patients probably suffered because of the proband’s death before 
completing the process of grief, but our study cannot explain 
them and we cannot arrive at a theoretical saturation against the 
point. Although the proband’s illness and death may be traumatic 
to the second patient, she may also draw strength by regarding the 
proband as a bellwether and pioneer. Moreover, the bellwether’s 
coping strategies and knowledge can accumulate among family 
members, and multiple patients within the family can cooperate. 
To become good bellwethers, the first and second patient must 
have some positive experiences. Therefore, medical staff should 
be aware of non-patients within the family and provide care that 
minimizes the trauma to these healthy relatives.
３．Protecting non-patient relatives by becoming two 
types of advocators
After disease onset, many second patients started Ⅳ . 
Advocating for blood relatives and （or） Ⅴ . Advocating beyond the 
family without obsessing with heredity.
The first form of advocacy involves accepting breast cancer as 
destiny by heredity. In this case, the patient copes by attempting 
to protect non-patient relatives （who are at statistically higher 
risk than the second patient was before diagnosis） using a flexible 
strategy for promoting prevention according to each relative’s 
age and personality. The coping strategy aims to decrease non-
patient relatives’ fear against breast cancer and to prevent negative 
influence of the disease on life events, such falling in love, 
marriage, and raising children.
This strategy is similar to Ⅰ. Caution without enforcement and 
Ⅱ. Intuition with high sensitivity, as explained by the earthquake 
analogy （Discussion Section 1）. Before onset, the second patient 
accepted the proband’s cancer with impact, but did not continue 
to think often about breast cancer. At the first sign of breast 
cancer, however, het intuition compels here to seek treatment as 
soon as possible. Both protecting non-patients and coping with 
the proband’s cancer can minimize negative influences on non-
patient relatives and help them prepare for a crisis. This attitude of 
forgetting breast cancer and enjoying life in health but “preparing 
for war” if cancer appears may be handed down from the proband 
and second patient to subsequent generations to facilitate coping 
with crisis while still allowing for a meaningful life.
The second patient was often hesitant to have a genetic test, 
and denied the singularity of the family despite two breast 
cancer patients. To cope, the second patient would become an 
advocate beyond her own family to enlighten other women about 
breast cancer. A positive genetic test means that the family must 
confront the fact that it harbors a breast cancer risk gene. Denying 
the influence of heredity and the uniqueness of the family as 
high risk are ways of avoiding and overcoming by generalization. 
By informing other women beyond the immediate family, the 
second patient can still enlighten and protect non-patient relatives 
without perceiving them as high risk or passing on this fear of 
risk to these relatives.
If heredity is clarified, non-patient relatives may let the fear 
of breast cancer interfere with their life aims. Nonetheless, they 
must be prepared for crisis because breast cancer risk is high. 
To resolve this conflict, the second patient may avoid clarifying 
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whether the family harbors a breast cancer risk gene and attempt 
to enlighten all non-patients regardless of blood relation. This is 
a positive, constructive, and realistic coping strategy for a high-
risk family and is in accord with a previous study on the decision-
making of healthy women testing positive for a BRCA mutation. 
They want to be logical and reduce their cancer risk, but emotions 
often complicate their decision-making due to the emotional 
desires of motherhood （Dean, 2017）. Clarifying heredity risk 
will force her to incorporate the possibility of breast cancer into 
her life plans. Therefore, certainty over gene risk may influence 
not only the woman but also her husband, parents, and children, 
as if she develops cancer and dies during child rearing her family 
will suffer （Kondo & Sato, 2011; Kondo & Sato, 2007）. If she 
decides not to get married and not to bear any children to avoid 
the sufferings of her children and husband due to her breast 
cancer and possible death, there is an increased possibility of the 
breakdown of the consanguineous family and cutting off of the 
family line.
In Japan, genetic testing is not as popular as in the USA 
（Sugano et al., 2008）, likely because patients think this 
knowledge may have negative impacts on healthy relatives. Other 
possible reasons are that 1） breast cancer risk is also influenced 
by environmental and lifestyle factors such as diet, breast-
feeding, and childbirth, 2） Japanese women may prefer the 
uncertainty to facing the reality of increased breast cancer risk, 
3） genetic testing does not completely exclude the possibility 
of familial breast cancer because the family may harbor genetic 
factors not yet associated with breast cancer risk, and 4） the 
scarcity of testing sites and genetic counselors in Japan.
Given the coping strategies demonstrated by second patients 
who do not wish certainty regarding genetic risk （Discussion 
Section 1）, we do not support medical staff pressuring patients 
to submit to genetic testing. Rather, medical staff should support 
the patient’s decision and start considering the needs of the 
entire family （including healthy female relatives） when the 
possibility of familial breast cancer is increasing, whether or 
not they seek genetic testing. Support after obtaining positive 
results is outside the scope of this study but warrants additional 
investigation.
As mentioned, the second patient often attempts to minimize 
the negative impact on non-patient relatives by either advocating 
specifically （encouraging regular examination, etc.） or to all 
women （beyond the family）. Medical staff should support these 
efforts and also support non-patient relatives directly and through 
the second patient whether or not the second patient is willing to 
undergo genetic testing for familial/hereditary breast cancer.
Ⅱ．Nursing strategies to enhance adaptation in a 
consanguineous family and to prevent cutting off of 
the family line through support of the second patient
The second patients’ coping strategies should be spread 
among the entire consanguineous family to reduce the anxiety 
of non-patients and minimize negative impacts on life decisions 
while still preparing against crises （breast cancer）. In this way, 
coping strategies of the proband （bellwether） and second 
patient are accumulated among family members. For these 
coping strategies to work for the family, it is critical to support 
the second patient, as she is the initial indicator of elevated 
genetic risk. Therefore, suitable support for second patients is 
support for the entire family at increased risk of familial breast 
cancer. We list specific recommendations for improving nursing 
as follows （See Table 4）. 
Ⅲ．Limitations and future research projects 
In this study, we did not select second patients with recurrence, 
metastasis, or terminal breast cancer to eliminate the influences 
of these burdens and focus on attitude and coping strategies. 
The second patients also had mixed experiences regarding the 
proband, who passed away in six cases. However, none of the 16 
participants experienced severe trauma from the proband’s death. 
Third, only one second patient had bilateral breast cancer. Four, 
we did not focus on breast cancer patients who had received 
clarification by genetic testing; rather, the focus was on patients 
and families with possible increased risk of familial breast cancer. 
Five, the participants of the study were Japanese outpatients in 
two Japanese hospitals.
Thus, although our result can explain the coping processes 
of second patients who were in good condition and did not 
feel trauma as a result of the first family member’s death, they 
cannot explain these strategies in families with clarity regarding 
hereditary breast cancer, a high probability of hereditary breast 
cancer, early onset cancer, or frequent metachronous breast 
cancer. Conversely, our results cannot sufficiently explain patients 
who determine hereditary breast cancer by genetic test, and 
family tree contained young adult patients and bilateral breast 
cancer patients and multi-organ multiple cancer. In addition, 
when researchers from other countries apply our results, they 
should consider how to take account of different nationalities, 
races, medical systems, and cultural backgrounds and should 
decide accordingly their applicability.
Further research must address the following issues. 1） We 
must examine how these strategies are disseminated among 
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Table 4　Nursing strategies to enhance adaptation as consanguineous family
1） Provide good palliative care for proband and second patient, because their sufferings will increase non-patient relatives’s fear againt cancer.
• Support proband’s and second patinet’s decision making with no regret.
• Gather information on the mental condition of non-patient relatives. If proband or second patient dies, provide them with grief care.
• If proband or second patient has young or have children, get to ask oncology clinical nursing specialists, and to educate general nurses 
about the suffering of cancer patients with children （Kondo & Sato, 2011）, the suffering of her a cancer patient’s husband （Kondo 
& Soto, 2007）, and grief care for children who have lost their mother （Forrest et al., 2006）
2）Explain the significance of articulating and expressing in words these experiences to allow the non-patinent relatives to inherit the 
bellwether’s and second patient’s coping strategies.
• Explain non-patient relatives about proband’s and second patient’s a path to cope with the illness. Through their example, suggest 
that non-patient relatives should recognize the negative as well as the hopeful aspects of their illness.
• Support communicating the proband’s and second patient’s coping strategy, because in certain cases, the proband and second patient 
cannot precisely define their coping strategy or gauge its effectiveness.
• Explain the importance of passing on these coping strategies to healthy relatives and the significance of accumulating these coping 
strategies within the consanguineouse family for future generations.
3）Support second patients for becoing two typese advocators.
• If the second patient cannot decide whether they should undergo genetic testing, this should be taken as aother means to protect 
non-patient relatives from stress and anxiety. 
• If the second patient wants to enlighten women beyond her consanguineous family, she should be provided the necessary medical 
information.
• Gather information about awareness activity for non-patient relatives, and consult the second patient how to communicate and 
conduct awareness activity without fear and stress. 
4）Start actively supporting non-patient relatives regardless of whether the second patient selects genetic testing.
• Explain to general nurses the significance of screening high-risk families against familial breast cancer.
• Explain to them the importance of constructing a family line. However, also explain the importance of protecting the patients privacy 
and stress that patients may not want to answer certain questions or share some information with others in the family.
• Explain to general nurses that familial breast cancer should be suspected when a second patient in the consanguineous family is 
diagnosed with breast cancer.  Patients as well as non-patient relatives should be supported.
• Explain that bilateral cancer or both breast cancer is a sign of familial breast cancer; therefore, the nurse should gather information 
about non-patient relatives. When gathering information, the nurse should listen with empathy, and pay attention to his/her own 
attitude so the proband’s fear does not increase.
5） Minimize negative influence in the life events and important decision-making situations of non-patient relatives.
• Provide information and care without causing anxiety in non-patients.
• Gather information from the second patient about whether specific information may negatively impact the lives and decisions of 
non-patient  relatives regarding marriage and family.
• Support the second patient in her efforts to reduce these negative impacts on her female relatives.
• If the second patient worries that non-patients might not take preventive actions against breast cancer, explain the difficulty of 
maintaining caution in daily life and the significance of working intuition when small breast abnormalities are noticed. In addition, 
explain to second patients the significance of narrowing down and proving non-patients with the essential information to promote 
working intuition as a measure to seek timely treatment.
• Our methods of support to non-patients should consider age and personality.
6）Support the decision of the second patient with respect to genetic testing.
• Consider whether genetic testing is in the family’s best interests and provide advice according to the wishes of the second patient.
• If the second patient cannot decide, advise that proband or second patient should discuss this issue with the consanguineous family 
considering both positive and negative impacts on specific family members. If a family member wants to talk to medical staff, listen 
and provide counseling to deepen and organize her thinking.
• Perform careful assessment of family history, current medical history of the proband and second patient （for example, bilateral breast 
cancer or other type of cancer）, the proband’s prognosis, malignance level, age of onset, etc. This allows prediction of familial breast 
cancer without genetic testing.
• This study alone is insufficient to provide decision-making support for genetic testing, so care after a positive result should consider 
the best research evidence （Dean & Rauscher, 2017; Scherr et al., 2016; Maheu, 2009; Cabrera et al., 2010） and involve trained 
genetic counselors.
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family members. While their statements suggested that these 
coping strategies will be inherited from former patient to 
subsequent patient, we did not directly examine inherited 
coping strategies among healthy relatives or subsequent （third） 
patients. We will conducted additional interviews of the proband 
as well as third and later patients to clarify how these strategies 
are passed on to the next generation. 2） We must also describe 
unique coping strategies of third and later patients in families as 
these patients are at even greater risk. 3） We need to examine 
how the proband’s death impacted the second and subsequent 
patients as continued grief counseling may be required. Indeed, 
the second or third patients may have poor prognosis. 4） We 
need to study ways to support families with positive results. 5） 
Finally, we need to conduct an interventional study to confirm 
whether the nursing methods suggested by these results can 
actually improve coping strategies among family members with 
possible familial breast cancer.
Conclusion
The central goal of the project is to provide coping strategies 
for a consanguineous family to cope with familial breast cancer 
so that they can compensate for the disadvantages associated 
with familial breast cancer and can develop the discontinuation 
of the family line. Although our target for support is a 
consanguineous family, as a first step, we focused on second 
patients within blood relatives. Because the reasons are the 
emergence of these cases increases the possibility of the disease 
being familial breast cancer, and the second patient within blood 
relatives to be diagnosed with breast cancer is thus the key 
person from whom the consanguineous family can assimilate 
coping strategies against family breast cancer.
Coping process against increased risk of familial breast cancer 
by second patients within blood relatives are explained as five 
core categories; Caution without enforcement, （before onset）, 
Intuition with high sensitivity （at signs of breast cancer）, 
Proband as a good bellwether, Advocating for blood relatives, 
and, Advocating beyond the family without obsessing with 
heredity （after onset）. The second patients characteristically 
protect non-patients by cooperating with the proband and 
by becoming two types of advocators. Based on these results, 
we suggest that consanguineous families may benefit by 
accumulating coping strategies that prepare for crisis while 
minimizing non-patient’s fear and negative impacts on future 
life decisions （such as marriage and having children）.
Research on support for families with heritable breast cancer 
is just beginning. Focusing on the second patient, whose breast 
cancer increases the possibility of familial breast cancer, may 
reveal novel strategies for improved treatment of both patients 
and healthy high-risk family members.
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要　　　旨
目的：家系で２人目の乳がん患者は，適応力を高め家系の存続を図る中核となる。本研究では，家系で２人目の
患者の家族性乳がんへの対処過程を明らかにし家系を守る支援を検討する。
方法：対象者16名に半構造化面接を行い，質的帰納的に分析した。
結果：発端者の闘病を目の当たりにした２人目患者は，乳がん発症前には強制力を伴わない警告と捉え深刻さを
和らげる一方，発症時には感度の高い直観が働き迅速な受診行動をとった。発症後は，発端者ががん適応の良き
導き手となると共に，発症リスクの高い未発症者を守る血族アドボケーターとなり，さらには遺伝性にとらわれ
ず家系を越えた啓発者となった。
考察：家族性乳がんの家系を守る支援は，未発症者の危機への備えを怠ることなく平時の不安を和らげ，女性の
ライフイベントへの悪影響を最小限にし，発端者と２人目発症者が獲得した対処方法を家系の知恵として蓄積，
共有することが示唆された。
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Abstract
Purpose: When the second patient is diagnosed with breast cancer, there is a high possibility that the disease is familial, and 
her ability to cope with the disease is essential for the family to adapt to the presence of familial breast cancer. This study 
aimed to understand the coping process of the second patient within blood relatives who has been diagnosed with familial 
breast cancer to identify effective nursing strategies.  
Method: Data were gathered using semi-structured interviews based on an interview guide and analyzed using qualitative 
and inductive research methods.  
Result: Sixteen patients were enrolled （age range: 40-72 years）. Core categories were Caution without enforcement （before 
onset）, Intuition with high sensitivity （at first breast cancer signs）, Proband as a good bellwether, Advocating for blood rela-
tives, and Advocating beyond the family without obsessing with heredity （all after diagnosis）.  
Discussion: Nursing strategies to enhance adaptation to familial breast cancer in a consanguineous family are 1） to reduce 
the anxiety of non-patients and to minimize the negative impacts on life decisions while still preparing against crises （breast 
cancer） and 2） to accumulate the coping strategies of the bellwethers among the consanguineous family.
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